Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Valsartan May Protect Against Pulmonary Hypertension

NCT06053580 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT06053580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Valsartan May Protect Against Pulmonary Hypertension
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Recruiting
Start date
February 28, 2024
Completion date
July 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, pulmonary vascular disorder, right heart failure, right ventricular dysfunction